首页> 外文OA文献 >A Human Platelet Receptor Protein Microarray Identifies the High Affinity Immunoglobulin E Receptor Subunit (Fc epsilon R1) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) Ligand
【2h】

A Human Platelet Receptor Protein Microarray Identifies the High Affinity Immunoglobulin E Receptor Subunit (Fc epsilon R1) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) Ligand

机译:人类血小板受体蛋白微阵列将高亲和力免疫球蛋白E受体亚基(Fc epsilon R1)鉴定为活化血小板内皮聚集受体1(PEAR1)配体。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Genome-wide association studies to identify loci responsible for platelet function and cardiovascular disease susceptibility have repeatedly identified polymorphisms linked to a gene encoding Platelet endothelium aggregation receptor 1 (PEAR1), an ″orphan″ cell surface receptor that is activated to stabilize platelet aggregates. To investigate how PEAR1 signaling is initiated, we sought to identify its extracellular ligand by creating a protein microarray representing the secretome and receptor repertoire of the human platelet. Using an avid soluble recombinant PEAR1 protein and a systematic screening assay designed to detect extracellular interactions, we identified the high-affinity immunoglobulin E (IgE)-binding subunit FcϵR1α, as a PEAR1 ligand. FcϵR1α and PEAR1 directly interacted through their membrane-proximal Ig-like and 13th EGF domains with a relatively strong affinity (KD ≈ 30nM). Pre-complexing FcϵR1α with IgE potently inhibited the FcϵR1α-PEAR1 interaction and this was relieved by the anti-IgE therapeutic, omalizumab. Oligomerised FcϵR1α potentiated platelet aggregation and led to PEAR1 phosphorylation, an effect that was also inhibited by IgE. These findings demonstrate how a protein microarray resource can be used to gain important insight into the function of platelet receptors, and provide a mechanistic basis for the initiation of PEAR1 signaling in platelet aggregation.
机译:全基因组关联研究确定了负责血小板功能和心血管疾病易感性的位点,已反复鉴定出与编码血小板内皮聚集受体1(PEAR1)的基因相关的多态性,该基因被激活以稳定血小板聚集的“孤儿”细胞表面受体。为了研究PEAR1信号是如何启动的,我们试图通过创建代表人类血小板的分泌组和受体组成的蛋白质微阵列来鉴定其细胞外配体。使用狂热的可溶性重组PEAR1蛋白和旨在检测细胞外相互作用的系统筛选方法,我们确定了高亲和力免疫球蛋白E(IgE)结合亚基FcϵR1α,为PEAR1配体。 FcϵR1α和PEAR1通过它们的膜近端Ig样和第13个EGF域直接相互作用,亲和力相对较高(KD≈30nM)。 FcϵR1α与IgE预先复合可有效抑制FcϵR1α-PEAR1相互作用,而抗IgE治疗药物omalizumab缓解了这种相互作用。寡聚化的FcϵR1α增强了血小板凝集并导致PEAR1磷酸化,这种作用也被IgE抑制。这些发现证明了如何使用蛋白质微阵列资源来获得对血小板受体功能的重要了解,并为血小板聚集中PEAR1信号的启动提供了机械基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号